AF
TECH icon

Amalgamated Financial’s Bio-Techne TECH Stock Holding History

Amalgamated Financial’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$6.73M Buy
+62,160
New +$6.41M 0.05% 321

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Amalgamated Financial's TECH Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Bio-Techne (TECH) in Q1 2022: 62,160 shares worth $6.73M. The stake represents 0.05% of the portfolio and ranks #321 among its holdings.

557 funds tracked by Wall St. Rank hold TECH as of Q1 2022.

  • Amalgamated Financial held 62,160 shares of Bio-Techne worth $6.73M as of Q1 2022.
  • Bio-Techne was a new Amalgamated Financial position in Q1 2022.
  • Bio-Techne made up 0.05% of Amalgamated Financial's portfolio in Q1 2022, its #321 holding.
  • 557 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.